European Archives - Page 3 of 1428 - European Medical Journal

ASCVD costs global health industry $680bn annually

Atherosclerotic cardiovascular disease costs global healthcare $680bn per year – the equivalent of Sweden’s entire economy, a new Office of Health Economics report has revealed.

New Risk Score Predicts Laryngeal Involvement in Pemphigus Vulgaris

Study introduces a clinical score to predict laryngeal involvement in pemphigus vulgaris, supporting targeted use of laryngoscopy.

Optimising Patient Outcomes in Advanced Gastrointestinal Stromal Tumours (GIST) in Europe

Corrigendum: Optimising Patient Outcomes in Advanced Gastrointestinal Stromal Tumours (GIST) in Europe

This infographic, which was originally published on 19.02.25, has been updated to provide a more simplified view of the ESMO EURACAN…

Reframing Vasoplegia in the ICU

Vasoplegia is defined as sustained low systemic vascular resistance in the context of a normal or high cardiac index, leading to…

EMJ Innovations 10 [Supplement 1] 2026

How do we reframe vasoplegia in the ICU? Experts Dan Longrois, Jean-Louis Vincent, Gianluca Paternoster, Ricard Ferrer, and Emily See…

Pancreatic Tumour Survival Prediction Model

A validated nomogram predicts survival in solid pseudopapillary neoplasm, showing strong accuracy and clinical utility across training, validation, and external cohorts.

GLP-1 Agonists Lower Complications and Mortality in Pancreatitis

A large multicentre study finds GLP-1 receptor agonists do not increase pancreatitis risk and are associated with fewer complications and lower mortality in Type 2 diabetes.

Ending HIV Testing May Raise Infections 10% by 2030

Ending CDC-funded HIV testing could raise infections by 10%, with rural areas most affected, highlighting the key role of early diagnosis.

Paediatric Autoimmune Hepatitis Cases Rise in Denmark

Paediatric autoimmune hepatitis incidence in Denmark has surged, yet most children maintain liver function with standard immunosuppressive therapy.

Is England Struggling to Meet Rising PET-CT Needs?

England delivered 50% fewer PET-CT scans than guidelines recommend in 2021, with gaps for prostate cancer, neuroendocrine tumours, and dementia.